Risperdal
$ 5,00 – $ 968,00Price range: $ 5,00 through $ 968,00
Robaxin
$ 40,00 – $ 150,00Price range: $ 40,00 through $ 150,00
Rizact
$ 51,00 – $ 510,00Price range: $ 51,00 through $ 510,00
Rizact is a highly effective medication specifically designed for the acute treatment of migraine headaches with or without aura. It belongs to a class of drugs called triptans, which work by narrowing swollen blood vessels in the brain to alleviate intense pain. In addition to stopping the headache, this formula helps reduce associated symptoms such as nausea and sensitivity to light or sound. Its fast-acting properties ensure that relief begins quickly, helping you return to your daily routine with minimal disruption. Rizact provides a targeted approach to managing active migraine episodes and improving overall comfort during an attack.
Active substance: Rizatriptan
SKU:
Rizact
Category: Pain Relief
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Rizact belongs to a class of medications known as selective serotonin receptor agonists, commonly referred to as triptans. It is specifically formulated for the acute medical management of migraine headaches with or without aura in adults. Dispensed strictly as a prescription (Rx) medication in accordance with federal and state regulations, this agent is not intended for the prophylactic prevention of migraine attacks or for managing other headache types.
Patients prescribed this pharmacological agent must understand its clinical purpose, mechanism of action, optimal timing of administration, and potential cardiovascular precautions. Proper evaluation by a licensed healthcare provider is necessary to establish an accurate migraine diagnosis prior to initiating treatment.
| Parameter | Specification |
|---|---|
| Active Ingredient | Rizatriptan benzoate |
| Therapeutic Class | Antimigraine Agent (5-HT1B/1D Receptor Agonist) |
| Dosage Form | Oral tablet / Orally disintegrating tablet |
| Route of Administration | Oral |
| Primary Purpose | Acute treatment of migraine attacks with or without aura |
| Prescription Status | Prescription (Rx) only |
Main Uses
Rizact is indicated exclusively for the acute treatment of migraine episodes in adult patients. It effectively targets headaches accompanied by neurological disturbances, known as aura, as well as migraine attacks occurring without aura. Clinical efficacy has been established for relieving the head pain, photophobia (sensitivity to light), phonophobia (sensitivity to sound), and functional impairment associated with acute migraine attacks.
This medication is not indicated for the preventive management or prophylaxis of migraine disorders. Furthermore, safety and effectiveness have not been established for cluster headaches, hemiplegic migraines, or basilar migraines. Prescribing guidelines require that a clear diagnosis of migraine be established by a physician before administering this drug to avoid misapplication in other cerebrovascular conditions.
How the Drug Works
The active constituent of Rizact, rizatriptan, acts as a selective agonist at serotonin 5-HT1B and 5-HT1D receptors located on intracranial blood vessels and sensory nerve endings of the trigeminal system. During a migraine attack, local cranial blood vessels dilate, and sensory nerve pathways release pro-inflammatory neuropeptides that generate pain signaling.
By selectively binding to 5-HT1B receptors on cranial vessels, the drug prompts localized vasoconstriction, reducing abnormal vascular dilation. Concurrently, binding to pre-junctional 5-HT1D receptors on trigeminal sensory nerves inhibits the peripheral release of vasoactive neuropeptides, including calcitonin gene-related peptide (CGRP) and substance P. This dual action interrupts central sensory transmission within the brainstem, thereby mitigating pain and associated autonomic symptoms.
Dosing Schedule
The standard single dose of Rizact for adult migraine treatment is 5 mg or 10 mg taken orally at the onset of a migraine headache. The selection of the starting dose depends on individual patient response and clinical evaluation by the prescriber. If headache relief is achieved after the initial dose but the migraine returns, a second dose may be administered provided at least 2 hours have elapsed since the first dose.
The maximum total daily dosage must not exceed 30 mg within a 24-hour period. For patients concomitantly taking the beta-blocker propranolol, the recommended single dose of rizatriptan is 5 mg, with a maximum limit of 15 mg (up to 3 doses) within a 24-hour window, due to metabolic interactions that elevate plasma concentrations of rizatriptan.
What Happens in the Body
Following oral administration, rizatriptan is rapidly and completely absorbed from the gastrointestinal tract. Peak plasma concentration (Cmax) is generally achieved in approximately 1 to 1.5 hours when taken under fasting conditions. Absolute oral bioavailability is approximately 45%, reflecting first-pass hepatic metabolism.
Rizatriptan undergoes primary oxidative deamination by monoamine oxidase-A (MAO-A) to form an inactive indole acetic acid metabolite. A minor active metabolite, N-monodesmethyl-rizatriptan, is formed to a lesser extent but contributes minimally to clinical activity. The mean plasma elimination half-life ranges between 2 and 3 hours in healthy adult subjects. Renal excretion accounts for approximately 82% of the total administered dose, primarily as the oxidative metabolite, while roughly 10% is excreted unchanged in the urine.
What to Avoid While Taking It
Food co-administration slows the absorption rate of rizatriptan, delaying peak plasma concentration by approximately 1 hour, although total extent of absorption (AUC) remains clinically unchanged. Patients requiring rapid onset of effect may consider taking the tablet on an empty stomach, provided gastrointestinal tolerance allows.
Ethanol consumption during a migraine attack should be strictly avoided. Alcohol serves as a recognized migraine trigger and can exacerbate central nervous system side effects such as drowsiness, dizziness, and impaired spatial coordination. Patients must refrain from consuming alcoholic beverages until the migraine attack has fully resolved and the medication has cleared from the systemic circulation.
Compatibility With Other Medicines
Rizact exhibits clinically significant interactions with several drug classes. Co-administration with monoamine oxidase inhibitors (MAO-A inhibitors) is strictly contraindicated; rizatriptan must not be used within 14 days of discontinuing MAO-A inhibitor therapy due to substantial increases in rizatriptan bio-availability and toxicity risk.
Concurrent administration with ergotamine-containing preparations, dihydroergotamine, or other 5-HT1 agonists (triptans) is prohibited. A separation period of at least 24 hours is required between taking rizatriptan and any ergot-type compound or alternative triptan to avoid additive vasospastic effects. Concomitant use with selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) carries a risk of serotonin syndrome, requiring immediate medical evaluation if agitation, hyperreflexia, or autonomic instability develops.
Adverse Reactions
Clinical trials indicate that Rizact is generally tolerated, though adverse effects can occur. Common transient adverse events reported in clinical evaluations include somnolence, dizziness, fatigue, dry mouth, nausea, and localized paresthesia (tingling or abnormal skin sensations).
Sensations of tightness, pain, pressure, or heaviness in the chest, throat, neck, or jaw are occasionally reported. While these sensations are frequently non-cardiac in origin, they warrant prompt clinical assessment to rule out underlying coronary ischemia. Overuse of acute migraine treatments, including rizatriptan (e.g., use on 10 or more days per month), may lead to medication overuse headache (rebound headache), characterized by increased migraine frequency requiring dosage withdrawal.
If You Skip a Dose
Because Rizact is prescribed strictly on an as-needed (PRN) basis for the acute abortive treatment of active migraine attacks, fixed daily dosing schedules do not apply. Missing a routine dose is not possible as the drug is not taken continuously.
If a migraine attack occurs and a dose is taken, patients must observe the mandatory minimum interval of 2 hours before considering a secondary dose if symptoms recur. Patients must never double a dose or take extra doses to compensate for a delayed initial treatment.
Important Precautions
Rizact is contraindicated in patients with established ischemic heart disease (such as myocardial infarction, angina pectoris, or documented silent ischemia), coronary artery vasospasm (including Prinzmetal’s angina), uncontrolled hypertension, peripheral vascular disease, or severe hepatic impairment. It is also contraindicated in individuals with a history of stroke, transient ischemic attack (TIA), or underlying cerebrovascular conditions.
Special clinical caution is required when prescribing to patients with cardiovascular risk factors (e.g., hypercholesterolemia, diabetes, smoking, strong family history of CAD, postmenopausal women, or men over 40 years of age) without prior cardiac evaluation. In pediatric populations (ages 6 to 17 years), safety guidelines vary by precise local jurisdiction and formulation weight bands. Use during pregnancy should occur only if the potential benefit justifies the potential fetal risk, as controlled human studies remain limited. Caution is advised during lactation, and consultation with a prescriber is required.
Storage and Expiration
Rizact tablets should be stored at controlled room temperature, typically between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). The medication must be kept in its original packaging to protect the tablets from moisture, light, and direct physical contamination.
Keep the medication securely out of the reach of children and pets. Do not use tablets past the expiration date printed on the blister pack or outer carton. Expired or unused medication should be disposed of via local pharmacy take-back programs or in accordance with federal waste guidelines, avoiding unmonitored flushing into public wastewater systems.
Practical Tips
For optimal therapeutic outcome, administration should occur at the earliest sign of a developing migraine headache. Patients should maintain a structured migraine diary recording attack frequency, triggers, timing of dose administration, and response to treatment to review during follow-up appointments.
Because rizatriptan can cause drowsiness and dizziness, patients should refrain from operating motor vehicles, navigating heavy machinery, or performing hazardous tasks until they have determined how the drug individually affects their alertness and psychomotor function.
Common Questions
How quickly does Rizact begin to work after administration?
Clinical studies demonstrate that onset of headache relief can begin as early as 30 minutes following administration, with peak efficacy typically observed within 1 to 2 hours. Absorption speed may be slightly slowed if taken immediately after high-fat meals. If no improvement is experienced after the initial dose, a second dose for the same attack is generally not recommended without consulting a physician.
Can Rizact be taken to prevent a migraine before symptoms start?
No, Rizact is not approved or clinically designed for migraine prophylaxis. It must only be taken once an acute migraine headache has actively commenced. Taking the medication prior to the onset of a migraine attack or during an isolated aura phase without headache has not been established as effective in preventing subsequent head pain.
What should be done if the first dose does not relieve the migraine?
If the first dose fails to provide any relief for a migraine attack, prescribing guidelines advise against taking a second dose for that same attack, as clinical utility for a repeated dose under those circumstances is unproven. Instead, alternative non-triptan acute abortive treatments approved by your prescriber may be considered. A second dose is reserved only for situations where the initial dose achieved relief but headache pain later returned.
Is it safe to drive after taking Rizact?
Rizact frequently causes central nervous system side effects such as drowsiness, dizziness, and fatigue. Patients must assess their individual physiological response to the medication before attempting to drive a vehicle or operate industrial equipment. If somnolence occurs, motor tasks must be deferred until full cognitive alertness is restored.
Why must a 24-hour gap be observed between Rizact and other migraine medications like ergotamine?
Both rizatriptan and ergotamine derivative drugs induce vasoconstriction of cranial and peripheral blood vessels through serotonin pathways. Combining these agents within a short timeframe creates a risk of additive, prolonged arterial vasospasm, which can severely compromise blood flow to heart tissues or peripheral limbs. Observing a strict 24-hour window between doses prevents dangerous physiological drug overlap.
In accordance with FDA requirements.
This material is educational. Only a licensed prescriber can determine whether a medication is appropriate for you.
Additional information
| Dosage |
5mg ,10mg |
|---|---|
| Package |
8 pills ,12 pills ,24 pills ,36 pills ,60 pills ,88 pills |
| Ενεργός Ουσία |
Related products
Azulfidine
$ 58,00 – $ 193,00Price range: $ 58,00 through $ 193,00
Active substance: sulfasalazine
More Details
This product has multiple variants. The options may be chosen on the product page
Benemid
$ 48,00 – $ 62,00Price range: $ 48,00 through $ 62,00
Active substance: Probenecidum
More Details
This product has multiple variants. The options may be chosen on the product page
Etodolac
$ 46,00 – $ 390,00Price range: $ 46,00 through $ 390,00
Active substance: Etodolac
More Details
This product has multiple variants. The options may be chosen on the product page
Flexeril
$ 57,00 – $ 648,00Price range: $ 57,00 through $ 648,00
Active substance: Cyclobenzaprine
More Details
This product has multiple variants. The options may be chosen on the product page
Lioresal
$ 52,00 – $ 478,00Price range: $ 52,00 through $ 478,00
Active substance: Lioresal
More Details
This product has multiple variants. The options may be chosen on the product page
Motrin
$ 9,00 – $ 278,00Price range: $ 9,00 through $ 278,00
Active substance: ibuprofen
More Details
This product has multiple variants. The options may be chosen on the product page
Periactin
$ 40,00 – $ 160,00Price range: $ 40,00 through $ 160,00
Active substance: Cyproheptadine
More Details
This product has multiple variants. The options may be chosen on the product page
Phenergan
$ 42,00 – $ 136,00Price range: $ 42,00 through $ 136,00
Active substance: Promethazine
More Details
This product has multiple variants. The options may be chosen on the product page
